Image_1_IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10.TIF
Neuroimmune–glia interactions have been implicated in the development of neuropathic pain. Interleukin-27 (IL-27) is a cytokine that presents regulatory activity in inflammatory conditions of the central nervous system. Thus, we hypothesized that IL-27 would participate in the neuropathic pain process. Here, we found that neuropathic pain caused by peripheral nerve injury (spared nerve injury model; SNI), was enhanced in IL-27-deficient(−/−) mice, whereas nociceptive pain is similar to that of wild-type mice. SNI induced an increase in the expression of IL-27 and its receptor subunit (Wsx1) in the sensory ganglia and spinal cord. IL-27 receptor was expressed mainly in resident macrophage, microglia, and astrocytes of the sensory ganglia and spinal cord, respectively. Finally, we identify that the antinociceptive effect of IL-27 was not observed in IL-10−/− mice. These results provided evidence that IL-27 is a cytokine produced after peripheral nerve injury that counteracts neuropathic pain development through induction of the antinociceptive cytokine IL-10. In summary, our study unraveled the role of IL-27 as a regulatory cytokine that counteracts the development of neuropathic pain after peripheral nerve damage. In conclusion, they indicate that immunotherapies based on IL-27 could emerge as possible therapeutic approaches for the prevention of neuropathic pain development after peripheral nerve injury.
History
References
- https://doi.org//10.1016/j.pain.2013.11.013
- https://doi.org//10.1038/nrn1700
- https://doi.org//10.1038/nri3621
- https://doi.org//10.1126/science.aaf8924
- https://doi.org//10.1016/j.cell.2009.09.028
- https://doi.org//10.1038/nrd4334
- https://doi.org//10.1016/S0306-4522(02)00065-9
- https://doi.org//10.1016/j.brainres.2011.10.016
- https://doi.org//10.1038/ncomms12029
- https://doi.org//10.1038/nrd1251
- https://doi.org//10.1016/j.pharmthera.2005.07.001
- https://doi.org//10.1038/nm.2123
- https://doi.org//10.1371/journal.pone.0028205
- https://doi.org//10.1172/JCI80883
- https://doi.org//10.1016/j.neulet.2015.03.001
- https://doi.org//10.1097/j.pain.0000000000001109
- https://doi.org//10.1016/S1074-7613(02)00324-2
- https://doi.org//10.4049/jimmunol.172.4.2225
- https://doi.org//10.1038/s41598-018-29398-3
- https://doi.org//10.1111/j.1365-2567.2010.03379.x
- https://doi.org//10.1002/glia.22948
- https://doi.org//10.1146/annurev-immunol-032414-112134
- https://doi.org//10.1038/ni1540
- https://doi.org//10.4049/jimmunol.174.12.7684
- https://doi.org//10.1016/j.imlet.2008.01.011
- https://doi.org//10.1189/jlb.0609445
- https://doi.org//10.4049/jimmunol.174.6.3534
- https://doi.org//10.1038/ni1375
- https://doi.org//10.4049/jimmunol.1400058
- https://doi.org//10.4049/jimmunol.179.5.3268
- https://doi.org//10.1136/ard.2007.083360
- https://doi.org//10.1002/art.30324
- https://doi.org//10.1016/j.cyto.2011.04.020
- https://doi.org//10.1073/pnas.252648899
- https://doi.org//10.1016/0092-8674(93)80068-P
- https://doi.org//10.1128/MCB.20.11.4106-4114.2000
- https://doi.org//10.1016/S0304-3959(00)00276-1
- https://doi.org//10.1016/0304-3959(87)90088-1
- https://doi.org//10.1016/0006-8993(83)90849-1
- https://doi.org//10.1016/0304-3959(94)90023-X
- https://doi.org//10.1590/S0100-879X2004000300018
- https://doi.org//10.1016/S0014-2999(99)00790-6
- https://doi.org//10.1016/0304-3959(87)90041-8
- https://doi.org//10.1006/meth.2001.1262
- https://doi.org//10.1038/nn.4053
- https://doi.org//10.1097/j.pain.0000000000001383
- https://doi.org//10.1016/j.jneuroim.2010.08.013
- https://doi.org//10.1111/j.1460-9568.2005.04057.x
- https://doi.org//10.1186/1742-2094-7-11
- https://doi.org//10.1111/j.1525-1403.2012.00462.x
- https://doi.org//10.1016/j.sjpain.2017.08.002
- https://doi.org//10.1213/01.ane.0000275190.42912.37
- https://doi.org//10.2147/JPR.S53660
- https://doi.org//10.1080/14728222.2017.1328057
- https://doi.org//10.1016/j.celrep.2016.04.063
- https://doi.org//10.1016/j.bbi.2009.12.007
- https://doi.org//10.1038/nn1992
- https://doi.org//10.1016/j.bbrc.2004.11.098
- https://doi.org//10.4049/jimmunol.179.10.6421
- https://doi.org//10.1016/j.pain.2005.04.013
- https://doi.org//10.1016/j.jneuroim.2008.01.005
- https://doi.org//10.1016/j.bbi.2006.10.012
- https://doi.org//10.1016/S0304-3959(97)00148-6
- https://doi.org//10.1002/1529-0131(199904)42:4<710::AID-ANR14>3.0.CO;2-4
- https://doi.org//10.1186/ar3064
- https://doi.org//10.1016/j.pain.2014.09.016
- https://doi.org//10.1016/j.bbi.2018.01.005
- https://doi.org//10.1016/j.bbi.2018.06.015
- https://doi.org//10.1016/j.expneurol.2013.01.018
- https://doi.org//10.1146/annurev.immunol.19.1.683
- https://doi.org//10.1016/j.jns.2013.03.002
- https://doi.org//10.1152/ajpgi.00329.2010
- https://doi.org//10.1016/0304-3959(83)90201-4
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity